OCT angiography biomarkers in type 1 choroidal neovascularisation after one year of aflibercept treatment

Aim: Our aim was to investigate the characteristics, treatment and prognosis of patients with myocardial infarction (MI) treated outside a cardiology department (CD), compared with MI patients treated at a CD. Methods: A cohort of 1310 patients diagnosed with MI at eight Swedish hospitals in 2011 were included in this observational study. Patients were followed regarding all-cause mortality until 2018. Results: A total of 235 patients, exclusively treated outside CDs, were identified. These patients had more non-cardiac comorbidities, were older (mean age 83.7 vs. 73.1 years) and had less often type 1 MIs (33.2% vs. 74.2%), in comparison with the CD patients. Advanced age and an absence of chest pain were the strongest predictors of non-CD care. Only 3.8% of non-CD patients were investigated with coronary angiography and they were also prescribed secondary preventive pharmacological treatments to a lesser degree, with only 32.3% having statin therapy at discharge. The all-cause mortality was higher in non-CD patients, also after adjustment for baseline parameters, both at 30 days (hazard ratio (HR) 2.28; 95% confidence interval (CI) 1.62–3.22), one year (HR 1.82; 95% CI 1.39–2.36) and five years (HR 1.62; 95% CI 1.32–1.98). Conclusions: MI treatment outside CDs is associated with an adverse short- and long-term prognosis. An improved use of percutaneous coronary intervention (PCI) and secondary preventive pharmacological treatment might improve the long-term prognosis in these patients.

Download Full-text

Renal function in type 1 diabetics one year after successful pancreas transplantation

Clinical Transplantation ◽

10.1111/j.1399-0012.2011.01458.x ◽

2011 ◽

Vol 25 (5) ◽

pp. E509-E515 ◽

Cited By ~ 7

Author(s):

Nikolaos A. Chatzizacharias ◽

Anil Vaidya ◽

Sanjay Sinha ◽

Richard Smith ◽

Gareth Jones ◽

...

Keyword(s):

Renal Function ◽

Pancreas Transplantation ◽

One Year

Download Full-text

Prevention of transmission of human T-lymphotropic virus type 1 (HTLV- 1) through transfusion, by donor screening with antibody to the virus. One-year experience

Transfusion ◽

10.1046/j.1537-2995.1989.29189101168.x ◽

1989 ◽

Vol 29 (1) ◽

pp. 7-11 ◽

Cited By ~ 57

Author(s):

S Inaba ◽

H Sato ◽

K Okochi ◽

K Fukada ◽

F Takakura ◽

...

Keyword(s):

Virus Type ◽

T Lymphotropic Virus ◽

Donor Screening ◽

One Year

Download Full-text

Use and Perception of Telemedicine in People with Type 1 Diabetes during the COVID-19 Pandemic: A One Year Follow-Up

Diabetes Technology & Therapeutics ◽

10.1089/dia.2021.0426 ◽

2021 ◽

Author(s):

Sam Scott ◽

Federico Fontana ◽

Simon Helleputte ◽

Jordan Pickles ◽

Markus Laimer ◽

...

Keyword(s):

Type 1 Diabetes ◽

One Year

Download Full-text

The effect of the COVID-19 pandemic on metabolic control in children with type 1 diabetes: a single-center experience

Journal of Pediatric Endocrinology and Metabolism ◽

10.1515/jpem-2021-0509 ◽

2021 ◽

Vol 0 (0) ◽

Author(s):

Emre Sarıkaya ◽

Dilek Çiçek ◽

Ebru Gök ◽

Leyla Kara ◽

Uğur Berber ◽

...

Keyword(s):

Type 1 Diabetes ◽

Metabolic Control ◽

Glycosylated Hemoglobin ◽

Emergency Admissions ◽

Single Center Experience ◽

Number Of Patients ◽

Significant Difference ◽

Before And After ◽

One Year

Abstract Objectives Coronavirus disease 2019 has caused a major epidemic worldwide, and lockdowns became necessary in all countries to prevent its spread. This study aimed to evaluate the effects of staying-at-home practices on the metabolic control of children and adolescents with type 1 diabetes during the pandemic period. Materials and Methods Eighty-nine patients younger than 18 years old who were diagnosed with type 1 diabetes at least one year before the declaration of the pandemic were included in the study. The last visit data of the patients before and after the declaration of the pandemic, and the frequency of presentation of diabetes-related emergencies from one year after diagnosis of type 1 diabetes to the declaration of the pandemic, and from the declaration of the pandemic to the last visit after the pandemic declaration were compared. Results The total number of patients was 89, and 48 (53.9%) were boys. The mean (± standard deviation [SD]) age at diagnosis was 8.4 ± 3.7 years (boys 7.9 ± 3.6 years; girls 8.9 ± 3.9 years). There was no statistically significant difference when the SD values of the anthropometric measurements, and the glycosylated hemoglobin (HbA1c) and lipid profile tests were compared. However, the frequency of admission to the emergency service related to diabetes was significantly different. Conclusions Although the pandemic did not significantly affect the metabolic and glycemic controls of the children with type 1 diabetes included in this study, an increase in the frequency of diabetes-related emergency admissions was noted.

Download Full-text

Subtyping of Pyocin Type 1 Pseudomonas aeruginosa: One Year of Experience

Applied Microbiology ◽

10.1128/aem.22.3.475-475.1971 ◽

1971 ◽

Vol 22 (3) ◽

pp. 475-475 ◽

Cited By ~ 3

Author(s):

Harold D. Rose ◽

Janice B. Babcock ◽

Margaret G. Heckman

Keyword(s):

Pseudomonas Aeruginosa ◽

One Year

Download Full-text

Improved Time-in-Range over 1 year is Associated with Reduced Albuminuria in Individuals with Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes

10.2337/figshare.12777122 ◽

2020 ◽

Author(s):

Ajenthen G. Ranjan ◽

Signe V. Rosenlund ◽

Tine W. Hansen ◽

Peter Rossing ◽

Steen Andersen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Pump ◽

Controlled Trial ◽

Daily Injection ◽

Albumin Creatinine Ratio ◽

Multiple Daily Injection ◽

Blood And Urine Samples ◽

Time In Range ◽

One Year

Aim: To investigate the association between treatment-induced change in continuous glucose monitored (CGM) time-in-range (TIR) and albuminuria in persons with type 1 diabetes (T1D) treated with sensor-augmented-pumps (SAP). Methods: <a></a><a>Twenty-six of fifty-five participants with albuminuria and multiple daily injection-therapy (25% females, 51 (46-63) years, HbA1c 75 (68-88) mmol/mol [9.0 (8.4-10.4)%], UACR 89 (37-250) mg/g) were in a randomized-controlled trial assigned to SAP-therapy for one year</a>. Anthropometrics, CGM-data, blood and urine samples were collected every three months. Results: Mean change (95%-CI) in %TIR was +13.2 (6.2;20.2)%, HbA1C was -14.4 (-17.4;-10.5) mmol/mol [-1.3 (-1.6;-1.0)%] and urinary albumin-creatinine-ratio (UACR) was -15 (-38;17)%, all p<0.05. UACR decreased with 19 (10;28)% per 10% increase in %TIR (p=0.04), 18 (1;30)% per 10 mmol/mol decrease in HbA1C (p=0.07), and 31% per 10 mmHg decrease in mean arterial pressure (p<0.001). Conclusion: In this longitudinal study, treatment-induced increase in %TIR was significantly associated with decrease in albuminuria in T1D.

Download Full-text